Dainippon Pharmaceutical Company Limited Company Profile

12:16 EDT 5th September 2015 | BioPortfolio

Antibiotics Diagnostics Veterinary

Location

6-8 Dosho-machi 2-chome Chuo-ku
Osaka
Osaka
541
Japan

Contact

Phone: 81 6 6203 5321
Fax: 81 6 203 6581


News Articles [16 Associated News Articles listed on BioPortfolio]

Sumitomo Dainippon licenses Servier to commercialize Latuda in Australia

Sumitomo Dainippon Pharma has concluded a license agreement with the Australian subsidiary of independent…

Sumitomo Dainippon and Takeda terminate Latuda collaboration

Japanese drug majors Sumitomo Dainippon Pharma and Takeda Pharmaceutical sare terminating their license…

Sumitomo Dainippon, Eli Lilly ink new sales collaboration

Biospectrum Based on this agreement, Eli Lilly Japan retains a manufacturing/marketing license for Trulicity and Sumito...

Sumitomo Dainippon Pharma Co. Ltd. and Takeda Pharmaceutical Company Limited Announce Decision to Terminate their Agreement for the Joint Development and Exclusive Commercialization of Latuda® (lurasidone) - an Atypical Antipsychotic Agent, in Europe

Osaka, Japan, May 7, 2015 – Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") (Head Office: Osaka, Japan: President: Masayo Tada) and Takeda Pharmaceutical Company Limited ("Take...

Sumitomo Dainippon, Takeda to terminate joint development deal of Latuda

Sumitomo Dainippon Pharma and Takeda Pharmaceutical will terminate their license agreement signed in March 2011 for the joint development and exclusive commercialization of pharmaceutical products con...

Eli Lilly signs sales collaboration agreement with Sumitomo Dainippon for Trulicity

Eli Lilly and Sumitomo Dainippon Pharma have signed a sales collaboration agreement for diabetes drug…

Sumitomo Dainippon, JCR Pharmaceuticals deal

Eli Lilly, Sumitomo Dainippon deal

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Dainippon Sumitomo Pharma Co., Ltd.

Dainippon Sumitomo Pharma Co., Ltd., (DSP), is a top-ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical, animal health and food and specialty products. DSP's strong...

Dainippon Sumitomo Pharma America, Inc.

Dainippon Sumitomo Pharma America, Inc. (DSPA) located in Fort Lee, N.J., is a subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP). On April 1, 2010, DSP's two North American operations - DSPA and...

Dainippon Pharmaceutical Company Limited

Antibiotics Diagnostics Veterinary

Chelsea Therapeutics International, Ltd.

Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical development company that acquires, develops and commercializes innovative products for the treatment of a variety of huma...

Sepracor Inc.

Sepracor Inc., an indirect, wholly-owned subsidiary of Dainippon Sumitomo Pharma Co., Ltd., is a research-based pharmaceutical company dedicated to treating and preventing human d...

More Information about "Dainippon Pharmaceutical Company Limited" on BioPortfolio

We have published hundreds of Dainippon Pharmaceutical Company Limited news stories on BioPortfolio along with dozens of Dainippon Pharmaceutical Company Limited Clinical Trials and PubMed Articles about Dainippon Pharmaceutical Company Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dainippon Pharmaceutical Company Limited Companies in our database. You can also find out about relevant Dainippon Pharmaceutical Company Limited Drugs and Medications on this site too.


Advertisement
 
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record